Reasons for global diagnostic preference as expressed by blinded readers
| Specifications of Global Diagnostic Preference | Preference Expressed | |||||
|---|---|---|---|---|---|---|
| Reader 1 (n = 52) | Reader 2 (n = 61) | Reader 3 (n = 56) | ||||
| Gadobenate Dimeglumine (n = 46) | Gadobutrol (n = 6) | Gadobenate Dimeglumine (n = 54) | Gadobutrol (n = 7) | Gadobenate Dimeglumine (n = 49) | Gadobutrol (n = 7) | |
| Superior contrast enhancement | 34 (73.9%) | 4 (66.7%) | 53 (98.1%) | 7 (100%) | 47 (95.9%) | 7 (100%) |
| Better delineation of normal structures | 0 | 0 | 1 (1.9%) | 0 | 1 (2.0%) | 0 |
| Better delineation of at least 1 lesion | 28 (60.9%) | 4 (66.7%) | 21 (38.9%) | 0 | 17 (34.7%) | 1 (14.3%) |
| Better visualization of lesion internal structure | 14 (30.4%) | 4 (66.7%) | 16 (29.6%) | 3 (42.9%) | 9 (18.4%) | 0 |
| Detection of more lesions | 2 (4.3%) | 0 | 1 (1.9%) | 1 (14.3%) | 3 (6.1%) | 0 |
| Greater diagnostic confidence | 2 (4.3%) | 0 | 2 (3.7%) | 0 | 3 (6.1%) | 0 |